MedTrace Logo

FLOAT Through Anxiety: Virtual Reality Application's Efficacy as a Tool to Distract From Negative Emotions and Thoughts

NCT06197464 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 62

Last updated 2024-04-17

No results posted yet for this study

Summary

The goal of this clinical trial is to examine the effectiveness and safety of the VR FLOAT application as a tool to reduce negative thoughts and feelings and anxiety symptoms in students with high levels of stress and anxiety. The main questions it aims to answer are:

1. Will subjects with high levels of anxiety who will use the FLOAT application experience a more significant relief in feelings of anxiety compared to subjects in the control group?
2. Will subjects who are used to using technology find greater comfort in using VR compared to subjects who are not used to it?
3. What is the degree of satisfaction with the use of VR and are there any reports of side effects?Participants will \[describe the main tasks participants will be asked to do, treatments they'll be given and use bullets Researchers will compare control group to see The comparison between using FLOAT as a regulation strategy after psychoeducation on emotional regulation and cognitive-behavioral use of a regulation strategy after the same psychoeducation

Conditions

  • Control
  • Experimental

Interventions

BEHAVIORAL

psychoeducation on emotional regulation and distraction strategy

The experimenter gives the subject psychoeducation about emotional regulation and distraction strategy with the help of a conversation and a presentation.

DEVICE

Using the FLOAT app on a virtual reality device

The subject should wear the VR device, and use the FLOAT application.

BEHAVIORAL

psychoeducation on emotional regulation and distraction strategy + Application

psychoeducation on emotional regulation and distraction strategy + Application

Sponsors & Collaborators

  • University of Haifa

    lead OTHER

Principal Investigators

  • YAEL ENAV, professor · University of Haifa

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-03-12
Primary Completion
2023-04-10
Completion
2024-01-20

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06197464 on ClinicalTrials.gov